Found 9 results
Name | Type of Offering | Accepted Date |
---|---|---|
Acurx Pharmaceuticals, LLC
|
D/A | 2018-10-30 13:07:18 |
Amount To Be Raised
$7,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001736243
Filed Document
0001736243-18-000004
Exclusions or Exemptions
506b
Accepted Date
2018-10-30 13:07:18
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
NEW YORK
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Acurx Pharmaceuticals, Inc.
|
D | 2025-03-20 21:13:41 |
Amount To Be Raised
$3,376,350
Associated Brokers / Dealers
N/A
CIK Number
0001736243
Filed Document
0001736243-25-000002
Exclusions or Exemptions
506b
Accepted Date
2025-03-20 21:13:41
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
NEW YORK
Revenue or Assets
Decline to Disclose
Type of Security
Option To Acquire
|
||
Acurx Pharmaceuticals, LLC
|
D | 2018-04-03 10:10:16 |
Amount To Be Raised
$7,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001736243
Filed Document
0001736243-18-000001
Exclusions or Exemptions
506b
Accepted Date
2018-04-03 10:10:16
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
NEW YORK
Revenue or Assets
No Revenues
Type of Security
Equity
|
||
Acurx Pharmaceuticals, Inc.
|
D | 2025-05-20 15:32:14 |
Amount To Be Raised
$12,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001736243
Filed Document
0001736243-25-000003
Exclusions or Exemptions
506b
Accepted Date
2025-05-20 15:32:14
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
NEW YORK
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Acurx Pharmaceuticals, LLC
|
D/A | 2018-05-31 15:13:05 |
Amount To Be Raised
$7,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001736243
Filed Document
0001736243-18-000003
Exclusions or Exemptions
506b
Accepted Date
2018-05-31 15:13:05
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
NEW YORK
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Acurx Pharmaceuticals, LLC
|
D | 2020-01-17 17:17:04 |
Amount To Be Raised
$6,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001736243
Filed Document
0001736243-20-000001
Exclusions or Exemptions
506b
Accepted Date
2020-01-17 17:17:04
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
NEW YORK
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Acurx Pharmaceuticals, LLC
|
D/A | 2019-10-30 13:39:24 |
Amount To Be Raised
$7,842,500
Associated Brokers / Dealers
N/A
CIK Number
0001736243
Filed Document
0001736243-19-000001
Exclusions or Exemptions
506b
Accepted Date
2019-10-30 13:39:24
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
NEW YORK
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Acurx Pharmaceuticals, Inc.
|
D | 2025-01-17 17:11:20 |
Amount To Be Raised
$2,404,259
Associated Brokers / Dealers
N/A
CIK Number
0001736243
Filed Document
0001736243-25-000001
Exclusions or Exemptions
506b
Accepted Date
2025-01-17 17:11:20
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
NEW YORK
Revenue or Assets
Decline to Disclose
Type of Security
Option To Acquire
|
||
Acurx Pharmaceuticals, Inc.
|
D | 2025-06-27 16:10:57 |
Amount To Be Raised
$3,978,664
Associated Brokers / Dealers
N/A
CIK Number
0001736243
Filed Document
0001104659-25-063623
Exclusions or Exemptions
506b
Accepted Date
2025-06-27 16:10:57
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
NEW YORK
Revenue or Assets
Decline to Disclose
Type of Security
Option To Acquire
|